Wednesday, February 24 th, 2016

(1)

(2)

List of Faculty:

Nadeem R. Abu-Rustum, Memorial Sloan Kettering Cancer Center. New York, USA

Giovanni Aletti, Istituto Europeo di Oncologia. Milan, Italy

Natalia Carballo, MD Anderson Cancer Center Madrid, Spain

David Cibula, General University Hospital in Prague, Charles University. Prague, The Czech Republic

Robert L. Coleman, The University of Texas MD Anderson Cancer Center. Houston, USA

Nicoletta Colombo, Istituto Europeo di Oncologia. Milan, Italy

Luis M. Chiva, MD Anderson Cancer Center Madrid, Spain

Ben Davidson, The Norwegian Radium Hospital. Oslo, Norway

Andreas du Bois, Kliniken Essen Mitte. Essen, Germany

Pedro F. Escobar, Instituto Gyneco-Oncológico. San Juan, Puerto Rico The University of Texas MD Anderson Cancer Center. Houston, USA

Anna Fagotti, Catholic University of the Sacred Heart. Rome, Italy

Michael M. Frumovitz, The University of Texas MD Anderson Cancer Center. Houston, USA

David M. Gershenson, The University of Texas MD Anderson Cancer Center. Houston, USA

Antonio González-Martín, MD Anderson Cancer Center Madrid, Spain

Anuja Jhingran, The University of Texas MD Anderson Cancer Center. Houston, USA

Matías Jurado, Clínica Universidad de Navarra. Pamplona, Spain

Jonathan A. Ledermann, UCL Cancer Institute, University College. London, United Kingdom

Mario M. Leitao, Memorial Sloan Kettering Cancer Center. New York, USA

Karen H. Lu, The University of Texas MD Anderson Cancer Center. Houston, USA

Andrea Mariani, Mayo Clinic, Rochester. Minnesota, USA

Christian Marth, Medical University Innsbruck, Austria

Sergio Martínez, Hospital Clínic Universitari. Barcelona, Spain

Ignacio Melero, Clínica Universidad de Navarra. Pamplona, Spain

Mansoor R. Mirza, Rigshospitalet, Copenhagen University Hospital. Copenhagen, Denmark

Gema Moreno, MD Anderson Cancer Center Madrid, Spain

Ana Oaknin, Hospital General Vall d’Hebron. Barcelona, Spain

José Palacios, Hospital Universitario Ramón y Cajal. Madrid, Spain

Sandro Pignata, National Cancer Institute Fondazione Pascale. Naples, Italy

Jordi Ponce, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat. Barcelona, Spain

Andrés Poveda, Fundación Instituto Valenciano de Oncología. Valencia, Spain

Eric Pujade-Lauraine, Hôpital Hôtel-Dieu. Paris, France

Denis Querleu, Institut Bergonié. Bordeaux, France

Pedro T. Ramirez, The University of Texas MD Anderson Cancer Center. Houston, USA

Andrés Redondo, Hospital Universitario La Paz. Madrid, Spain

Ignacio Romero, Fundación Instituto Valenciano de Oncología. Valencia, Spain

Anil Sood, The University of Texas MD Anderson Cancer Center. Houston, USA

Gemma Toledo, MD Anderson Cancer Center Madrid, Spain

(3)

12:00 12:15 WELCOME

REMARKS

Dr. Luis M. Chiva

MD Anderson Cancer Center Madrid, Spain

Dr. Pedro T. Ramirez

The University of Texas MD Anderson Cancer Center. Houston, USA

Dr. Antonio González-Martín

DEALING WITH RARE OVARIAN TUMORS

Moderators: Dr. Antonio González-Martín

Dr. Luis M. Chiva

12:15 - 12:35 Updates on novel therapies for rare tumors:

From chemotherapy to innovative therapies

Dr. David Gershenson

12:35 - 12:55 Overview of histopathologic classifications of rare tumors

Dr. Gemma Toledo

12:55 - 13:20 Discussion

13:20 - 15:00 Lunch

15:00 - 15:20 KEYNOTE LECTURE

Hereditary cancer genetics in the era of targeted therapies

Dr. Karen H. Lu

Professor and Chair H.E.B. Professorship in

Cancer Research Department Gynecologic Oncology & Reproductive Medicine The University of Texas MD Anderson Cancer Center. Houston, USA

15:20 - 15:30 Discussion

15:30 - 16:00 INAUGURATION BY AUTHORITIES

W

edn

es

da

y, F

eb

ru

ary 24

th

, 2016

(4)

FROM LABORATORY MEDICINE

TO INNOVATIVE CLINICAL APPLICATIONS:

FOSTERING INNOVATION IN CONVERTING RESEARCH

DISCOVERIES TO CLINICAL IMPACT

Moderators: Dr. Gema Moreno

Dr. José Palacios

Hospital Universitario Ramón y Cajal. Madrid, Spain

Dr. Ignacio Romero

Fundación Instituto Valenciano de Oncología. Valencia, Spain

16:00 - 16:20 Intra-tumor heterogeneity: Biological

and clinical implications

Dr. José Palacios

Hospital Universitario Ramón y Cajal. Madrid, Spain

16:20 - 16:40 Gene panel testing in gynecological cancer:

From the lab to the clinical practice

Dr. Gema Moreno

16:40 - 17:00 Clinical implications of molecular analysis

of serous effusions in ovarian cancer

Dr. Ben Davidson

The Norwegian Radium Hospital. Oslo, Norway

17:00 - 17:15 Discussion

17:15 - 17:45 Coffee break

17:45 - 18:05 Immunostimulatory monoclonal antibodies changing

the landscape of gyn-cancer treatment

Dr. Ignacio Melero

Clínica Universidad de Navarra. Pamplona, Spain

18:05 - 18:25 Targeting angiogenesis in ovarian cancer:

Overcoming adaptive responses

Dr. Anil Sood

18:25 - 18:45 Harnessing homologous recombination deficiency

for specialized treatment of ovarian cancer patients

Dr. Robert L. Coleman

18:45 - 19:00 Discussion

W

edn

es

da

y, F

eb

ru

ar

y 24

th

, 2016

(5)

INDIVIDUALIZING THERAPY

IN ADVANCED OVARIAN CANCER

Moderators: Dr. Andreas du Bois

Kliniken Essen Mitte. Essen, Germany

Dr. Sergio Martínez

Hospital Clínic Universitari. Barcelona, Spain

08:30 - 08:50 Assessment of quality in ovarian cancer surgery:

The ESGO perspective

Dr. Denis Querleu

Institut Bergonié. Bordeaux, France Dr. Luis M. Chiva

08:50 - 09:10 Laparoscopic evaluation to assess cytoreduction

Dr. Anna Fagotti

Catholic University of the Sacred Heart. Rome, Italy

09:10 - 09:30 Clinical and radiologic assessment of feasibility

of

cytoreduction

Dr. Giovanni Aletti

Istituto Europeo di Oncologia. Milan, Italy

09:30 - 09:50 Predictors of residual disease in patients

with ovarian cancer

Dr. Anil Sood

09:50 - 10:10 Adjuvant therapy in advanced ovarian cancer:

Moving beyond carboplatin and paclitaxel

Dr. Christian Marth

Medical University Innsbruck, Austria

10:10 - 10:40 Discussion

10:40 - 11:00 Coffee break

Th

ur

sd

ay, F

eb

ru

ary 25

th

, 2016

(6)

INTEGRATING RECENT ADVANCES

INTO OPTIMIZING TREATMENT FOR WOMEN

WITH RECURRENT OVARIAN CANCER

Moderators: Dr. Andrés Poveda

Fundación Instituto Valenciano de Oncología. Valencia, Spain

Dr. Luis M. Chiva

11:00 - 11:20 Selecting the “really” ideal patient

for secondary cytoreduction

Dr. Andreas du Bois

11:20 - 11:40 Chemotherapy in the recurrent ovarian cancer setting:

Relying on the “old standard” or is novel therapy

the new standard?

Dr. Sandro Pignata

National Cancer Institute Fondazione Pascale. Naples, Italy

11:40 - 12:00 Critical review of PARPi’s in ovarian cancer therapy:

How are we going to use them and when?

Dr. Jonathan A. Ledermann

UCL Cancer Institute, University College. London, United Kingdom

12:00 - 12:20 Integrating biological therapies in recurrent disease:

Looking for the perfect algorithm

Dr. Eric Pujade-Lauraine

Hôpital Hôtel-Dieu. Paris, France

12:20 - 12:40 Endpoints in ovarian cancer trials: Insights

from the 2015 SGO/ASCO/AACR FDA endpoints workshop

12:40 - 13:10 Discussion

13:10 - 14:40 Lunch

Th

ur

sd

ay

, F

eb

ru

ar

y 25

th

, 2016

(7)

SENTINEL LYMPH NODE IN GYNECOLOGIC ONCOLOGY:

A TIME TO SET NEW STANDARD OF CARE

Moderators: Dr. Jordi Ponce

Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat. Barcelona, Spain

Dr. Michael M. Frumovitz

Dr. Pedro F. Escobar

Instituto Gyneco-Oncológico. San Juan, Puerto Rico

14:40 - 15:00 Cervical cancer: Can we stop performing complete

lymphadenectomy?

Dr. David Cibula

General University Hospital in Prague, Charles University. Prague, The Czech Republic

15:00 - 15:40 Endometrial cancer: Memorial Sloan-Kettering

vs. Mayo Clinic

Dr. Nadeem R. Abu-Rustum

Memorial Sloan Kettering Cancer Center. New York, USA

Dr. Andrea Mariani

Mayo Clinic, Rochester. Minnesota, USA

15:40 - 16:00 Vulvar cancer: Updates on current data and future trials

Dr. Ate Van der Zee

University Medical Center of Groningen, Netherlands

16:00 - 16:20 Discussion

16:20 - 16:40 Personalizing targeted therapy in advanced/metastatic

cervical cancer: The challenge of anti-angiogenesis therapy

Dr. Ana Oaknin

Hospital General Vall d’Hebron. Barcelona, Spain

16:40 - 16:50 Discussion

16:50 - 17:10 Coffee break

Th

ur

sd

ay, F

eb

ru

ary 25

th

, 2016

(8)

UPDATES ON THE MANAGEMENT

OF ENDOMETRIAL CANCER

Moderators: Dr. Natalia Carballo

Dr. Andrés Redondo

Hospital Universitario La Paz. Madrid, Spain

Dr. Matías Jurado

Clínica Universidad de Navarra. Pamplona, Spain

17:10 - 17:30 Current and future clinical trials

in advanced/recurrent endometrial cancer

Dr. Mansoor R. Mirza

Rigshospitalet, Copenhagen University Hospital. Copenhagen, Denmark

17:30 - 17:50 Updates on standard care and novel approaches

for radiation oncology in uterine cancer

Dr. Anuja Jhingran

17:50 - 18:10 Reaching a consensus in endometrial cancer:

European guidelines (ESGO-ESTRO-ESMO)

Dr. Nicoletta Colombo

Istituto Europeo di Oncologia. Milan, Italy

18:10 - 18:30 Discussion

Th

ur

sd

ay

, F

eb

ru

ar

y 25

th

, 2016

(9)

PERSONALIZED MEDICINE IN GYNECOLOGIC

ONCOLOGY: LOOKING BEYOND STANDARDS

Moderator: Dr. Luis M. Chiva

MD Anderson Cancer Center Madrid, Spain Dr. Karen H. Lu

08:30 - 08:45 Influence of life style and psychological support

in gynecologic oncology

08:45 - 09:00 Targeting stress neuroendocrine pathways in cancer

Dr. Anil Sood

09:00 - 09:15 Enhance recovery after surgery (ERAS)

09:15 - 09:30 Discussion

09:30 - 09:45 SGO ANNUAL MEETING INVITATION

09:45 - 10:45 TUMOR BOARD

Moderators: Dr. Pedro T. Ramirez

Dr. Luis M. Chiva

Panel: Dr. David Gershenson Dr. Karen H. Lu Dr. Nadeem R. Abu-Rustum Dr. Andreas du Bois Dr. Nicoletta Colombo Dr. Anuja Jhingran Dr. José Palacios Dr. Pedro F. Escobar

Frid

ay, F

eb

ru

ary 26

th

, 2016

(10)

10:45 - 11:15 MD ANDERSON SPAIN FOUNDATION AWARDS

A life devoted to a great endeavour: Gynecologic oncology

Dr. Andreas du Bois

11:15 - 11:45 Coffee break

INNOVATIONS IN MINIMALLY

INVASIVE SURGERY

Moderators: Dr. Pedro T. Ramirez

Dr. Michael M. Frumovitz

11:45 - 12:05 Update on robotic surgery in gynecologic oncology

Dr. Mario M. Leitao

12:05 - 12:25 Role of single-port surgery by laparoscopy or robotics:

Surgical innovation or a procedure without a future?

Dr. Pedro F. Escobar

Instituto Gyneco-Oncológico. San Juan, Puerto Rico

12:25 - 12:45 Discussion

12:45 - 13:45 SURGICAL FILM FESTIVAL

Moderators: Dr. Mario M. Leitao

Dr. David Cibula

General University Hospital in Prague, Charles University. Prague, The Czech Republic

13:45 - 13:55 CLOSING REMARKS

Dr. Luis M. Chiva

Fr

id

ay

, F

eb

ru

ar

y 26

th

, 2016

(11)

Local Committee:

Sonsoles Alonso Javier García Prado Marisa Argente Antonio González-Martín Elsa Bernal Luis Granados

Raquel Bratos Fernando Lapuente Natalia Carballo Pilar López Mendo Teresa Castellanos Raúl Márquez

Luis M. Chiva Mar Mendivil

Virginia Corraliza Gema Moreno Marta de la Fuente Mª Jesús Pablos Irene Fernández Gemma Toledo Juan Fernando García Covadonga Vidal

(12)